Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 20. xxxxxxxxx 2014

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx x mimořádná xxxxxxxx xxx rok 2015

Xxxxxxxxxxxx zdravotnictví xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx a o xxxxx některých souvisejících xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační xxxxxx xxxxxxxxx složení očkovacích xxxxx pro pravidelná, xxxxxxxx a xxxxxxxxx xxxxxxxx pro rok 2015:

1. Xxxxxxxxx složení xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx

1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx haemagglutinum filamentosum

Pertussis xxxxxxxxx externae xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx min.

Antigenum xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 2

Virus xxxxxxxxxxxxxxx inactivatum xxxxx 3

Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Xxxxxxxxxxx influenzae x, Tetani xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná forma), xxxxxx xxxxxxxxxx B, xxxxxxx vyvolaným Haemophilus xxxxxxxxxx xxx x ( DTaPHibVHBIPV)

Diphtheriae anatoxinum

Tetani xxxxxxxxxx

Xxxxxxxx Bordetelly xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx xxxxxxxxxxxx

Xxxxx Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Mahoney)

typus 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx tegiminis hepatitidy X

Xxxxxxxxxxx influenzae typu x polysaccharidum

(Polyribosylribitoli phasphas)

conjugata xxx xxxxxx xxxxxxxxxx

1x) xxxxxxxx látka proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx jednotek

Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 mikrogramů

1c) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx b (DTaPHib):

Diphtheriae xxxxxxxxxx ........................................... xxx. 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx .................................................... min. 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx X ....................................... 10 mikrogramů

cum xxxxxxxxx xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x:

1 dávka xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx xxxxxx:

Xxxxxx anatoxinum ................................................... min. 40 xxxxxxxxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X do 15 let xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx 16 let x výše:

Antigenum tegiminis xxxxxxxxxxx B ........................... 20 xxxxxxxxxx

1x) očkovací xxxxx xxxxx spalničkám, xxxxxxxxxx x zarděnkám:

Morbillorum xxxxx xxxxxxxxxx (Schwarz) xxx. 10^3,0 infekční xxxxx xxx xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx virus attenuatum (XXX 4385) xxx. 10^3,7 xxxxxxxx xxxxx xxx buněčnou xxxxxxx₅₀

Xxxxxxxx xxxxx xxxxxxxxxx (Wistar XX 27/3) xxx. 10^3,0 infekční dávka xxx xxxxxxxx kulturu₅₀

1ch) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x inaktivované xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 xxxxxxxxxxx X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 2 (XXX-1) ................ 8 xxxxxxxxxxx X xxxxxxxx*

Xxxxx poliomyelitis xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx D xxxxxxxx*

* xxxx xxxxxxxx ekvivalentních xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx v polysacharidové xxxxxxx:

Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10A, 11 X, 12X, 14, 15X, 17X, 18C, 19X, 19X, 20, 22X, 23F, 33F ...... 25 xxxxxxxxxx x xxxxxxx xxxxxxxx

1x) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Pneumococcale xxxxxxxxxxxxxxx sérotypus 3

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6A

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 18C

Pneumococcale xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X

1xx) xxxxxxxx xxxxx proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx xxxxxxxxxx ............................... xx xxxx xxx 2 mezinárodní xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx než 20 xxxxxxxxxxxxx jednotek

Pertusové xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 D xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X jednotek antigenu

typus 3 (xxxx Xxxxxxx) ................................ 32 X xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx toxoid ....................................... xxxx xxxx xxxxx 2 xxxxxxxxxxx xxxxxxxx (2 Xx)

Xxxxxxxxx xxxxxx ....................................... xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx xxxxxxxxxxxx ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 1 (inaktivovaný) ... 40 xxxxxxxxxxx X xxxxxxxx

Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) ... 8 xxxxxxxxxxx X xxxxxxxx

Xxxxx poliomyelitis xxxx 3 (inaktivovaný) ... 32 antigenních X xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx tuberkulóze:

Mycobacterium xxxxx attenautum (XXX) xxxxxxx Xxxxxxx 1331 ... 0,75 mg ≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) očkovací xxxxx xxxxx xxxxxx hepatitidě X xxx xxxxx xxxxxxxx xx dialyzačního xxxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; xxxxxxxx AS04C xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 mikrogramů x 1 xxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx xxxxxxxx

2x) očkovací xxxxx xxxxx virové xxxxxxxxxx X xx formuli xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) očkovací xxxxx xxxxx vzteklině

Virus xxxxxx xxxxxxxxxxx (xxxx Wistar xxxxxx PM/WI 38&xxxx;1503-3X xxxx xxxx xxxxx 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 xxxxx (0,5 ml)

2c) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx pro dospělé:

Hepatitis X xxxxx xxxxxxxxxxx

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:

Hepatitis A xxxxx xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx děti:

Virus xxxxxxxxx A xxxxxxxxxxx

X xxxx 2015 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx xxxxxxx, nelze xxxxxxxx xxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. x.

Informace

Právní xxxxxxx x. 278/2014 Xx. nabyl xxxxxxxxx xxxx 13.12.2014.

Ke xxx xxxxxxxx xxxxxx xxxxxxx nebyl xxxxx xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem jiných xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.